Early clinical effectiveness and safety of remibrutinib in chronic spontaneous Urticaria: A prospective multicenter real-world study. // Allergy Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2949913526000352?dgcid=rss_sd_all
Early clinical effectiveness and safety of remibrutinib in chronic spontaneous Urticaria: A prospective multicenter real-world study. Allergy Medicine. https://www.sciencedirect.com/science/article/pii/S2949913526000352?dgcid=rss_sd_all
“Early clinical effectiveness and safety of remibrutinib in chronic spontaneous Urticaria: A prospective multicenter real-world study.” Allergy Medicine.
@article{article34239,
title = {Early clinical effectiveness and safety of remibrutinib in chronic spontaneous Urticaria: A prospective multicenter real-world study},
journal = {Allergy Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2949913526000352?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez